SIBIONICS, named the third largest brand of continuous glucose monitoring (CGM) systems in the world, announced that it will exhibit at the 17th International Conference on Advanced Technologies and Treatments for Diabetes (ATTD). The event takes place from March 6 to 9, 2024 in Florence, Italy. The company’s booth at the conference will display its latest CGM solutions for diabetes management.
The company shared that it has successfully partnered with over 1,800 hospitals to integrate their CGM for hospital treatment, benefiting more than 850,000 people globally in diabetes control. In addition, SIBIONICS is in the process of building an automated production line with an annual capacity of 18 million CGM devices, set to be completed in 2024.
SIBIONICS received CE MDR certification in October 2023, entering the European market in November. The company quickly expanded its global partnerships with a strong product offering and positive user reviews. In the year 2024, SIBIONICS is committed to customer-centric innovation and engaging with users to co-develop a CGM solution that precisely aligns with their needs. The company highlights the importance of blood glucose control and aims to offer high-quality, comprehensive diabetes solutions to improve overall health, focusing on type 1 diabetes, type 2 diabetes, prediabetes, and metabolic disorders.
During the ATTD conference, the company will host an event titled “SIBIONICS Influencer Talk: Realizing the Unimagined” on March 9, 2024. This event will bring together healthcare professionals, dieticians, and thought leaders in the field of diabetes management to discuss the broad potential of CGM technology and its critical role in developing future solutions for diabetes management.
The “SIBIONICS Influencer Talk: Realizing the Unimagined” event will feature engaging discussions on the company’s upcoming launch plans for new versions of the CGM GS1 – GS2, reusable transmitter – GS ECO, and the combined glucose and ketone monitor. The event will also include thought-provoking and interactive question-and-answer sessions, creating a vibrant atmosphere conducive to diabetes management solutions co-developed by users. The event is set to take place at the Hilton Garden Inn Florence Novoli in Florence, Italy and the company extends its gratitude to all the speakers and brand partners who will be attending.
The company looks forward to continuing the conversation and pushing the boundaries of CGM innovation at its future events. For anyone who wants to learn more about this exciting event, we would be happy to provide you with additional information.
Source link
